|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007097,
umls-concept:C0016980,
umls-concept:C0020823,
umls-concept:C0030705,
umls-concept:C0040808,
umls-concept:C0042670,
umls-concept:C0205177,
umls-concept:C0205179,
umls-concept:C0227598,
umls-concept:C0282460,
umls-concept:C1512162
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-1-29
|
|
pubmed:abstractText |
This study was conducted to assess the efficacy and toxicity of vinblastine, ifosfamide, and gallium nitrate (VIG) as first-line chemotherapy in patients with locally advanced or metastatic carcinoma of the urothelium.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
79
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
110-4
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:8988734-Adenocarcinoma,
pubmed-meshheading:8988734-Adult,
pubmed-meshheading:8988734-Aged,
pubmed-meshheading:8988734-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8988734-Carcinoma, Transitional Cell,
pubmed-meshheading:8988734-Female,
pubmed-meshheading:8988734-Gallium,
pubmed-meshheading:8988734-Humans,
pubmed-meshheading:8988734-Ifosfamide,
pubmed-meshheading:8988734-Male,
pubmed-meshheading:8988734-Middle Aged,
pubmed-meshheading:8988734-Urinary Bladder Neoplasms,
pubmed-meshheading:8988734-Vinblastine
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Vinblastine, ifosfamide, and gallium nitrate--an active new regimen in patients with advanced carcinoma of the urothelium. A phase II trial of the Eastern Cooperative Oncology Group (E5892).
|
|
pubmed:affiliation |
Department of Medicine, University of Iowa, Iowa City, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Clinical Trial, Phase II
|
